Physician profile
James M Libby
NPI 1326146507
$7,308.79
in general payments reported to CMS, 2019-2025
16 companies · $223 in 2025
The $223 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,018 · 2020: $99.92 · 2021: $356 · 2022: $240 · 2023: $140 · 2024: $232 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $594.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Metuchen Pharmaceuticals | $5,291.67 | 2019 | |
| Coloplast Corp | $403.50 | 2019-2025 | |
| Astellas Pharma US INC | $388.03 | 2019-2021 | |
| Boston Scientific Corporation | $263.49 | 2021-2025 | Rezum Generator, Axonics, Spaceoar Vue System - 10ml |
| Myovant Sciences INC. | $237.93 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $210.86 | 2023-2025 | Orgovyx |
| Koelis INC. | $153.69 | 2024 | |
| Medical Device Business Services, INC. | $123.83 | 2019 | |
| Laborie Medical Technologies Corp. | $65.29 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Blue Earth Diagnostics | $46.10 | 2019-2021 | |
| Convatec INC. | $42.62 | 2022 | |
| Merck Sharp & Dohme LLC | $24.51 | 2025 | Lynparza, Keytruda Qlex, Keytruda |
| Abbvie INC. | $18.43 | 2019 | |
| Teleflex LLC | $18.38 | 2025 | Barrigel |
| Acerus Pharmaceuticals Corporation | $14.15 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $6.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Libby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.